A new study using
brevetoxin-2, a compound produced naturally by marine algae, stimulated nerve
cell growth and plasticity in cultured mouse neurons. This research advances a
potentially new pharmacological treatment to aid recovery of brain function
following a stroke or other traumatic brain injury.
Stroke is a leading
cause of death in the United States with more than 795,000 people suffering a
stroke each year, according to the Center for Disease Control. Stroke is a
leading cause of serious long-term disability and there is currently no drug
treatment for post-stroke rehabilitation.
"Our research
suggests that compounds like brevetoxin-2 can augment neuronal plasticity
potentially providing a neural repair therapy for stroke recovery. If that
outcome can be supported by further studies in animals and subsequently humans,
it could have a profound impact on a currently non-treatable condition,"
said Thomas F. Murray, Ph.D. associate vice president for Health Science
Research and professor and chair of the Department of Pharmacology, Creighton
School of Medicine.
The research team from
Creighton University School of Medicine, University of North Carolina
Wilmington, and Scripps Institution of Oceanography published their findings in
the Nov. 12 online edition of the journal Proceedings of the National
Academy of Sciences (PNAS).
The tiny marine
dinoflagellate Karenia brevis produces brevetoxin, which in high concentrations
is responsible for the harmful algal blooms known as red tides that occur in
the waters off the west coast of Florida. The neurotoxin-laden red tide causes
respiratory irritation in humans and central nervous system paralysis in fish.
"Brevetoxin is a
neurotoxin that is known to activate nerves cells to fire spontaneously,"
said Dan Baden, Ph.D. He is director of the Center for Marine Science as well
as a founding member and Executive Principal of MARBIONC at University of North
Carolina Wilmington. "It's a great advancement to show that this naturally
occurring ocean compound can stimulate nerve cell growth in cultured mouse
cells."
Brevetoxin is one of
more than 1,000 ocean organisms cultured at the University of North Carolina
Wilmington's MARBIONC facility (Marine Biotechnology in North Carolina) for use
in bio-medical research. The bioactive materials from Karenia brevis have been
actively studied by Baden since the early 1970s. A clot that restricts blood
flow to an area of the brain causes a stroke. Although the dead tissue cannot
be revived, the brain can be trained to redirect nerve impulses to living nerve
cells nearby.
Recent scientific
studies have shown that rewiring of nerve cells following a stroke occurs as a
result of heightened plasticity around the brain's damaged cerebral cortex,
which is the area of the brain responsible for sensory and cognitive nervous
system functions.
This new study showed
enhanced neuronal sprouting, the growth of axons or dendrites of a nerve cell
as well the formation of new synapses between nerve cells in mouse neurons in a
culture dish.
Source:
The above story is
reprinted from materials provided
byCreighton University.
Note: Materials may be
edited for content and length. For further information, please contact the
source cited above.
Journal Reference:
1. J. George, D. G. Baden, W. H. Gerwick, T. F.
Murray.Bidirectional influence of sodium channel activation on NMDA
receptor-dependent cerebrocortical neuron structural plasticity. Proceedings
of the National Academy of Sciences, 2012; DOI: 10.1073/pnas.1212584109
Disclaimer: This article is not intended to provide
medical advice, diagnosis or treatment. Views expressed here do not necessarily
reflect those of Eagle Group or its staff.
0 comments:
Post a Comment